Search research articles
Contact Us
Filters
Showing results (181-190 of 195) with videos related to
Page
of 20
Sort By:
The Journal of Antimicrobial Chemotherapy
|
April 1, 1989
Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients
J D Grange, A Gouyette, L Gutmann, et al.
European Journal of Clinical Pharmacology
|
April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?
S Morin, M A Loriot, J M Poirier, et al.
European Journal of Clinical Pharmacology
|
March 14, 2003
Genetic and environmental risk factors for oral anticoagulant overdose
C Verstuyft, A Robert, S Morin, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1990
Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients
A Rames, J M Poirier, F LeCoz, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1988
Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration
B Lecocq, P Jaillon, V Lecocq, et al.
Annales De Biologie Clinique
|
June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]
C Verstuyft, S Morin, J Yang, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1989
Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients
P Jaillon, M E Gardin, B Lecocq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators
P M Girard, M Guiguet, D Bollens, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
December 1, 1989
[Electrophysiologic effects of intravenous 3-hydroxy-dihydroquinidine (LNC-834) in man]
J Weissenburger, J Y le Heuzey, J Clementy, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1985
[Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole]
P Dumoulin, P Jaillon, A Kher, et al.
Page
of 20
Search research articles
Search
Showing results (181-190 of 195) with videos related to
Sort By:
Page
of 20
The Journal of Antimicrobial Chemotherapy
|
April 1, 1989
Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients
J D Grange, A Gouyette, L Gutmann, et al.
European Journal of Clinical Pharmacology
|
April 11, 2001
Is diclofenac a valuable CYP2C9 probe in humans?
S Morin, M A Loriot, J M Poirier, et al.
European Journal of Clinical Pharmacology
|
March 14, 2003
Genetic and environmental risk factors for oral anticoagulant overdose
C Verstuyft, A Robert, S Morin, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1990
Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients
A Rames, J M Poirier, F LeCoz, et al.
Journal of Cardiovascular Pharmacology
|
October 1, 1988
Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration
B Lecocq, P Jaillon, V Lecocq, et al.
Annales De Biologie Clinique
|
June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]
C Verstuyft, S Morin, J Yang, et al.
Clinical Pharmacology and Therapeutics
|
August 1, 1989
Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patients
P Jaillon, M E Gardin, B Lecocq, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 26, 2000
Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators
P M Girard, M Guiguet, D Bollens, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
December 1, 1989
[Electrophysiologic effects of intravenous 3-hydroxy-dihydroquinidine (LNC-834) in man]
J Weissenburger, J Y le Heuzey, J Clementy, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|
October 1, 1985
[Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole]
P Dumoulin, P Jaillon, A Kher, et al.
Page
of 20